Skip to main content

Table 3 Comparison of characteristics and VAS levels at entry recorded during and outside the pollen season

From: Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study

  

During pollen season (n = 6939)

Outside pollen season (n = 2098)

P value

Symptoms Day 1

 

Itchy nose (%)

73

66

<0.001

 

Sneezing (%)

61

55

<0.001

 

Congestion (%)

69

65

0.001

 

Red eyes (%)

46

37

<0.001

 

Itchy eyes (%)

68

53

<0.001

 

Watery eyes (%)

47

38

<0.001

Impact of symptoms Day 1

 

Sleep (%)

38

35

0.06

 

Daily activities (%)

45

39

<0.001

 

Work/school (%)

30

26

<0.001

 

Bothersome (%)

76

68

<0.001

ARIA score (%)

0

14

20

 
 

1

30

32

 
 

2

25

21

<0.001

 

3

18

16

 
 

4

14

12

 
 

Median [p25-p75]

2 [1–3]

1 [1–3]

<0.001

  1. FF Fluticasone Furoate, FP Fluticasone Propionate, MF Mometasone Furoate, MPAzeFlu Azelastine-Fluticasone Propionate
  2. *Chi square tests were used for categorical variables (i.e. baseline symptoms and impact of symptoms, ARIA score); Kruskal–Wallis tests were used for continuous variables (i.e. ARIA score)
  3. p25: 25th percentile; p75: 75th percentile
Back to article page

Clinical and Translational Allergy

ISSN: 2045-7022

Contact us